Journal of the Korean Association of Oral and Maxillofacial Surgeons

The Korean Association of Oral and Maxillofacial Surgeons (대한구강악안면외과학회)
권호 표지
DOI QR코드

DOI QR Code

Osteosarcoma of the jaws in Koreans: analysis of 26 cases

  • Jeong, Hye-In (Department of Oral and Maxillofacial Surgery, Yonsei University College of Dentistry) ;
  • Lee, Mi Jee (Oral Cancer Research Institute, Yonsei University College of Dentistry) ;
  • Nam, Woong (Department of Oral and Maxillofacial Surgery, Yonsei University College of Dentistry) ;
  • Cha, In-Ho (Department of Oral and Maxillofacial Surgery, Yonsei University College of Dentistry) ;
  • Kim, Hyung Jun (Department of Oral and Maxillofacial Surgery, Yonsei University College of Dentistry)
  • Received : 2017.06.22
  • Accepted : 2017.10.04
  • Published : 2017.10.31
Download PDF
⟨ Previous Next ⟩

Abstract

Objectives: In order to assess clinical behavior, response to treatment, and factors influencing prognosis of Korean patients with osteosarcoma of the jaws (OSJ). Materials and Methods: A retrospective study of clinical, and pathological records of 26 patients with OSJ treated at the Department of Oral and Maxillofacial Surgery in Yonsei University Dental Hospital from 1990 to March 2017. Results: Of 26 patients, there were 9 men (34.6%) and 17 women (65.4%). Twenty-one of 26 patients had osteosarcoma of the mandible, and 5 of 26 patients had osteosarcoma of the maxilla. The histopathology of OSJ is highly variable, ranging from chondroblastic type (6 out of 26), osteoblastic type (10 out of 26), fibroblastic type (2 out of 26), to the rare variants like mixed type, small cell osteosarcoma types and more. All patients underwent gross total excision and only a few patients underwent neoadjuvant chemotherapy. Postoperative chemotherapy was given to most of the patients as adjuvant treatment or in combination with radiotherapy. The overall survival rate was 73.1% with an overall 2-year survival rate of 83.3%. The overall 5-,10-,15-year survival rates in this study were 73.5%, 73.5%, 49%, respectively. Using Kaplan-Meier analysis with log rank tests, the size of tumor (T-stage), and resection margins were found to affect the survival rate significantly. The chemotherapy was not significantly associated with improved survival rate. Conclusion: Surgical resection with a clear margin is the most important factor in disease survival. The role of chemotherapy and radiotherapy in OSJ remains controversial, and deserves further studies.

Keywords

References

  1. Garrington GE, Scofield HH, Cornyn J, Hooker SP. Osteosarcoma of the jaws. Analysis of 56 cases. Cancer 1967;20:377-91. https://doi.org/10.1002/1097-0142(1967)20:3<377::AID-CNCR2820200306>3.0.CO;2-T
  2. Russ JE, Jesse RH. Management of osteosarcoma of the maxilla and mandible. Am J Surg 1980;140:572-6. https://doi.org/10.1016/0002-9610(80)90215-9
  3. Rosen G, Caparros B, Huvos AG, Kosloff C, Nirenberg A, Cacavio A, et al. Preoperative chemotherapy for osteogenic sarcoma: selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy. Cancer 1982;49:1221-30. https://doi.org/10.1002/1097-0142(19820315)49:6<1221::AID-CNCR2820490625>3.0.CO;2-E
  4. Rosen G. Preoperative (neoadjuvant) chemotherapy for osteogenic sarcoma: a ten year experience. Orthopedics 1985;8:659-64.
  5. Smeele LE, Kostense PJ, van der Waal I, Snow GB. Effect of chemotherapy on survival of craniofacial osteosarcoma: a systematic review of 201 patients. J Clin Oncol 1997;15:363-7. https://doi.org/10.1200/JCO.1997.15.1.363
  6. Kassir RR, Rassekh CH, Kinsella JB, Segas J, Carrau RL, Hokanson JA. Osteosarcoma of the head and neck: meta-analysis of nonrandomized studies. Laryngoscope 1997;107:56-61. https://doi.org/10.1097/00005537-199701000-00013
  7. Carrle D, Bielack SS. Current strategies of chemotherapy in osteosarcoma. Int Orthop 2006;30:445-51. https://doi.org/10.1007/s00264-006-0192-x
  8. August M, Magennis P, Dewitt D. Osteogenic sarcoma of the jaws: factors influencing prognosis. Int J Oral Maxillofac Surg 1997;26:198-204.
  9. Oda D, Bavisotto LM, Schmidt RA, McNutt M, Bruckner JD, Conrad EU 3rd, et al. Head and neck osteosarcoma at the University of Washington. Head Neck 1997;19:513-23. https://doi.org/10.1002/(SICI)1097-0347(199709)19:6<513::AID-HED9>3.0.CO;2-1
  10. Lee RJ, Arshi A, Schwartz HC, Christensen RE. Characteristics and prognostic factors of osteosarcoma of the jaws: a retrospective cohort study. JAMA Otolaryngol Head Neck Surg 2015;141:470-7. https://doi.org/10.1001/jamaoto.2015.0340
  11. Fernandes R, Nikitakis NG, Pazoki A, Ord RA. Osteogenic sarcoma of the jaw: a 10-year experience. J Oral Maxillofac Surg 2007;65:1286-91. https://doi.org/10.1016/j.joms.2006.10.030
  12. Kammerer PW, Shabazfar N, Vorkhshori Makoie N, Moergel M, Al-Nawas B. Clinical, therapeutic and prognostic features of osteosarcoma of the jaws: experience of 36 cases. J Craniomaxillofac Surg 2012;40:541-8. https://doi.org/10.1016/j.jcms.2011.10.001
  13. Ferrari D, Codeca C, Battisti N, Broggio F, Crepaldi F, Violati M, et al. Multimodality treatment of osteosarcoma of the jaw: a single institution experience. Med Oncol 2014;31:171. https://doi.org/10.1007/s12032-014-0171-9
  14. Smith RB, Apostolakis LW, Karnell LH, Koch BB, Robinson RA, Zhen W, et al. National Cancer Data Base report on osteosarcoma of the head and neck. Cancer 2003;98:1670-80. https://doi.org/10.1002/cncr.11716
  15. Jasnau S, Meyer U, Potratz J, Jundt G, Kevric M, Joos UK, et al. Craniofacial osteosarcoma: experience of the cooperative German-Austrian-Swiss osteosarcoma study group. Oral Oncol 2008;44:286-94. https://doi.org/10.1016/j.oraloncology.2007.03.001
  16. Canadian Society of Otolaryngology-Head and Neck Surgery Oncology Study Group. Osteogenic sarcoma of the mandible and maxilla: a Canadian review (1980-2000). J Otolaryngol 2004;33:139-44. https://doi.org/10.2310/7070.2004.03013
  17. Granowski-LeCornu M, Chuang SK, Kaban LB, August M. Osteosarcoma of the jaws: factors influencing prognosis. J Oral Maxillofac Surg 2011;69:2368-75. https://doi.org/10.1016/j.joms.2010.10.023
  18. Ajagbe HA, Junaid TA, Daramola JO. Osteogenic sarcoma of the jaw in an African community: report of twenty-one cases. J Oral Maxillofac Surg 1986;44:104-6. https://doi.org/10.1016/0278-2391(86)90190-4
  19. Kragh LV, Dahlin DC, Erich JB. Osteogenic sarcoma of the jaws and facial bones. Am J Surg 1958;96:496-505. https://doi.org/10.1016/0002-9610(58)90965-6
  20. Lee YB, Kim NK, Kim JY, Kim HJ. Low-grade osteosarcoma arising from cemento-ossifying fibroma: a case report. J Korean Assoc Oral Maxillofac Surg 2015;41:48-51. https://doi.org/10.5125/jkaoms.2015.41.1.48
  21. Hauben EI, Weeden S, Pringle J, Van Marck EA, Hogendoorn PC. Does the histological subtype of high-grade central osteosarcoma influence the response to treatment with chemotherapy and does it affect overall survival? A study on 570 patients of two consecutive trials of the European Osteosarcoma Intergroup. Eur J Cancer 2002;38:1218-25. https://doi.org/10.1016/S0959-8049(02)00037-0
  22. Paparella ML, Olvi LG, Brandizzi D, Keszler A, Santini-Araujo E, Cabrini RL. Osteosarcoma of the jaw: an analysis of a series of 74 cases. Histopathology 2013;63:551-7.
  23. Smeele LE, Snow GB, van der Waal I. Osteosarcoma of the head and neck: meta-analysis of the nonrandomized studies. Laryngoscope 1998;108:946. https://doi.org/10.1097/00005537-199806000-00030

Cited by

  1. Radiologic/histologic discrepancies in tumour identification: The case of a “basketball‐sized” mandibular tumour in a woman from 17th century West Virginia vol.28, pp.6, 2017, https://doi.org/10.1002/oa.2703
  2. Lack of efficacy of neoadjuvant chemotherapy in adult patients with maxillo-facial high-grade osteosarcomas: A French experience in two reference centers vol.95, pp.None, 2017, https://doi.org/10.1016/j.oraloncology.2019.06.011
  3. Knockdown of microRNA-203 reduces cisplatin chemo-sensitivity to osteosarcoma cell lines MG63 and U2OS in vitro by targeting RUNX2 vol.33, pp.5, 2021, https://doi.org/10.1080/1120009x.2021.1899441
  4. Carbon-ion radiotherapy in osteosarcoma of the mandible: a case report vol.47, pp.4, 2017, https://doi.org/10.5125/jkaoms.2021.47.4.315
  5. Osteosarcoma of the anterior maxilla mimicking a periapical pathology: A case report vol.47, pp.3, 2021, https://doi.org/10.1111/aej.12491